| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/25/2013 | CN103315992A Liquiritigenin oral preparation, injection preparation and preparation method thereof |
| 09/25/2013 | CN103315985A Application of Fingolimod in preparing medicine for inhibiting liver cancer intrahepatic metastasis |
| 09/25/2013 | CN103315984A Applications of Fingolimod in preparation of drugs for inhibiting IL-6 secretion of hepatoma cells, |
| 09/25/2013 | CN103315981A Application of biphenol and/or derivatives thereof in preparation of drugs for inhibiting cancer cell metastasis |
| 09/25/2013 | CN103315978A Dry docetaxel elixir, and preparation method and application thereof |
| 09/25/2013 | CN103315977A Folic acid modified quercetin lipid nano-capsule preparation and preparation method thereof |
| 09/25/2013 | CN103315967A Nedaplatin-containing freeze-drying composition as well as application and preparation method thereof |
| 09/25/2013 | CN103315961A Neogambogic acid self-microemulsifying preparation and preparation method thereof |
| 09/25/2013 | CN103315956A Mustard oil nanoemulsion and preparation method thereof |
| 09/25/2013 | CN103315949A Thymopent aqueous solution preparation and use thereof |
| 09/25/2013 | CN103315945A Vascular embolic agent as well as injection device and application thereof |
| 09/25/2013 | CN103315304A Rabdosia rubescens Chinese herbal beverage and preparation method thereof |
| 09/25/2013 | CN102935239B Preparation for preventing or treating lung cancers and preparation method and application thereof |
| 09/25/2013 | CN102920702B Dihydroartemisinin and Chinese blister beetle composition, enteric preparation and application and preparation thereof |
| 09/25/2013 | CN102784395B Application of MAPK-ERK1/2 signal channel inhibitor to preparation of double-minute medicine for removing or inhibiting tumor cells |
| 09/25/2013 | CN102727779B Pharmaceutical composition for treating ovarian cysts and preparation method thereof |
| 09/25/2013 | CN102727522B Compound double-release capsule preparation composed of bromodihydroartemisinin and Fe<2+> agent |
| 09/25/2013 | CN102670660B Processing method and application of aspongopus |
| 09/25/2013 | CN102631414B SepHaniadelavayi Diels total alkaloid extraction and purification technology |
| 09/25/2013 | CN102627767B Potential of hydrogen (pH) response random copolymer based on poly-beta amino ester and preparation method and application thereof |
| 09/25/2013 | CN102614506B Recombinant HPV16L2 protein vaccine and preparation method thereof |
| 09/25/2013 | CN102552541B Medicinal composition for preventing or treating breast cancer |
| 09/25/2013 | CN102532250B Przewalsikone A compound with anti-tumor activity and preparation method and application thereof |
| 09/25/2013 | CN102526705B Application of human ribosomal protein L23 label peptide in preparation of anti-cancer medicines |
| 09/25/2013 | CN102443011B Levorotatory fluoroquinolone C3 diazole methyl sulfide quaternary ammonium salt, preparation method and application thereof |
| 09/25/2013 | CN102432595B N-indole-1-amides compounds and application of N-indole-1-amides compounds as anti-cancer drugs |
| 09/25/2013 | CN102416029B Ginseng submicron powder and preparation method and preparation thereof |
| 09/25/2013 | CN102302476B Dehydrobufotenine dry power inhaler and preparation method and application thereof |
| 09/25/2013 | CN102240359B Traditional Chinese medicine for preventing and treating recurrence of esophageal cancer after radiotherapy and resisting side reactions of radiotherapy |
| 09/25/2013 | CN102219768B Perylenequinone compounds and their extraction and separation method and use |
| 09/25/2013 | CN102178931B Recombinant human interleukin-12 preparation for injection and preparation method thereof |
| 09/25/2013 | CN102174105B Antibodies directed to HER-3 and uses thereof |
| 09/25/2013 | CN102056589B Solid pharmaceutical formulations comprising BIBW 2992 |
| 09/25/2013 | CN101991619B Pomegranate controlled-release pellets and preparation method thereof |
| 09/25/2013 | CN101679434B 2, 6, 9-substituted purine derivatives having anti proliferative properties |
| 09/25/2013 | CN101674820B Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| 09/25/2013 | CN101601648B Sub-microemulsion used for intravenous injection of polyene yew alcohol phospholipid composite and preparation method thereof |
| 09/25/2013 | CN101547924B Compounds for inhibiting mitotic progression |
| 09/25/2013 | CN101475636B Human interferon-like protein and use thereof |
| 09/25/2013 | CN101400785B Method for production of t cell population |
| 09/25/2013 | CN101248180B Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
| 09/25/2013 | CN101239190B Vitamin receptor binding drug delivery conjugates |
| 09/24/2013 | US8541442 Indole derivatives as anticancer agents |
| 09/24/2013 | US8541429 Pyrazolo quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 09/24/2013 | US8541425 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 09/24/2013 | US8541390 Treatment of cancer by inhibition of IGFBPs and clusterin |
| 09/24/2013 | US8541376 Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 09/24/2013 | US8540964 Polyvalent conjugate vaccine for cancer |
| 09/24/2013 | CA2770851C Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/24/2013 | CA2755554C Pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 09/24/2013 | CA2691587C Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a] pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4, tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepin |
| 09/24/2013 | CA2682064C Compositions for targeted imaging and therapy |
| 09/24/2013 | CA2640652C Novel coumarin derivative having antitumor activity |
| 09/24/2013 | CA2632466C Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 09/24/2013 | CA2628461C Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
| 09/24/2013 | CA2615254C Combinations of pyrimidylaminobenzamide bcr-abl inhibitors and mtor inhibitors for the treatment of leukemia |
| 09/24/2013 | CA2591321C Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase |
| 09/24/2013 | CA2584343C Pharmaceutical compositions comprising a camptothecin derivate |
| 09/24/2013 | CA2542691C Il-6 antagonist for use as mesothelioma therapeutic agent |
| 09/24/2013 | CA2540809C Lpa receptor agonists and antagonists and methods of use |
| 09/24/2013 | CA2486583C Marker molecules associated with lung tumors |
| 09/24/2013 | CA2448427C Molecules and methods for inhibiting shedding of kim-1 |
| 09/24/2013 | CA2434760C Differentiated cells suitable for human therapy |
| 09/24/2013 | CA2405557C Albumin fusion proteins |
| 09/19/2013 | WO2013138790A1 Combination therapies including inhibitors of the extracellular domain of e-cadherin |
| 09/19/2013 | WO2013138716A1 The filamentous bacteriophage as an angiogenesis modulator |
| 09/19/2013 | WO2013138697A1 Methods and materials for treating cancer |
| 09/19/2013 | WO2013138691A1 Methods of predicting clinical outcome of chronic lymphocytic leukemia |
| 09/19/2013 | WO2013138666A1 Inhibitors of furin and other pro-protein convertases |
| 09/19/2013 | WO2013138665A1 Inhibitors of furin and other pro-protein convertases |
| 09/19/2013 | WO2013138612A1 Synthesis and application of novel imaging agents conjugated to dpa 713 analogs for imaging inflammation |
| 09/19/2013 | WO2013138600A1 Radioprotector compounds |
| 09/19/2013 | WO2013138557A1 Treatment of cancer with tor kinase inhibitors |
| 09/19/2013 | WO2013138556A1 Treatment of cancer with tor kinase inhibitors |
| 09/19/2013 | WO2013138553A1 Treatment of cancer with tor kinase inhibitors |
| 09/19/2013 | WO2013138505A1 Selective cell targeting using adenovirus and chemical dimers |
| 09/19/2013 | WO2013138484A1 Method to prevent cancer metastasis and inhibit inflammation by inhibition of p68 interaction with calmodulin |
| 09/19/2013 | WO2013138396A1 Dihydropyridopyrimidine and dihydronaphthyridine derivatives as tyrosine kinase inhibitors of especially vegf and pdgf |
| 09/19/2013 | WO2013138361A1 Inhibitors of human ezh2, and methods of use thereof |
| 09/19/2013 | WO2013137920A1 Engineered conformationally-stabilized proteins |
| 09/19/2013 | WO2013137686A1 Gremlin-1 antibody |
| 09/19/2013 | WO2013137495A1 Replication competent pseudo-type retrovirus vector system |
| 09/19/2013 | WO2013137433A1 Novel antitumor agent comprising combination of three agents |
| 09/19/2013 | WO2013137427A1 Novel pyrimidine nucleoside compound |
| 09/19/2013 | WO2013137396A1 NOVEL INTEGRIN α9β1 LIGAND AND USES THEREOF |
| 09/19/2013 | WO2013137328A1 Method for screening anticancer drugs, and anticancer drug that induces cell death and uses substance that increases granzyme m activity as active ingredient |
| 09/19/2013 | WO2013136254A1 Heterocyclyl compounds |
| 09/19/2013 | WO2013136086A1 A negative modulator of hedgehog signalling for use in treating th2 -mediated diseases |
| 09/19/2013 | WO2013135800A1 Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood |
| 09/19/2013 | WO2013135745A1 Methods of treating melanoma with pak1 inhibitors |
| 09/19/2013 | WO2013135727A1 Glioma treatment by convection enhanced delivery |
| 09/19/2013 | WO2013135648A1 Substituted pyrrolidine-2-carboxamides |
| 09/19/2013 | WO2013135612A1 Substituted imidazopyridazines |
| 09/19/2013 | WO2013135588A1 Novel binding molecules with antitumoral activity |
| 09/19/2013 | WO2013135266A1 Treatment of non-small cell lung carcinoma by active immunotherapy |
| 09/19/2013 | WO2013135189A1 Solid dispersion improving absorption performance and preparation of same |
| 09/19/2013 | WO2013135187A1 Solid dispersion of improved adsorption performance and preparation thereof |
| 09/19/2013 | WO2013135176A1 Aminoquinazoline derivative and use thereof in preparing anti-malignant tumor medicament |
| 09/19/2013 | WO2013135147A1 Use of substituted diphenylamine compounds in preparing anti-tumour drugs |
| 09/19/2013 | WO2013135119A1 Fusarium oxysporum extract and use thereof |